Cargando…
Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors
Recent technological and conceptual advances have resulted in a plethora of exciting novel engineered adeno associated viral (AAV) vector variants. They all have unique characteristics and abilities. This review summarizes the development and their potential in treating Parkinson’s disease (PD). Cli...
Autores principales: | Björklund, Tomas, Davidsson, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543274/ https://www.ncbi.nlm.nih.gov/pubmed/34366370 http://dx.doi.org/10.3233/JPD-212674 |
Ejemplares similares
-
A novel process of viral vector barcoding and library preparation enables high-diversity library generation and recombination-free paired-end sequencing
por: Davidsson, Marcus, et al.
Publicado: (2016) -
Viral gene delivery vectors: the next generation medicines for immune-related diseases
por: De Haan, Peter, et al.
Publicado: (2020) -
Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy
por: El Ashkar, Sara, et al.
Publicado: (2017) -
Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing
por: Davidsson, Marcus, et al.
Publicado: (2018) -
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
por: Wahane, Aniket, et al.
Publicado: (2020)